Blueprint Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-633
| Closed | -$220K | – | 151 |
|
|
2023
Q3 | $220K | Sell |
633
-221
| -26% | -$76.9K | 0.07% | 102 |
|
|
2023
Q2 | $301K | Buy |
+854
| New | +$301K | 0.11% | 119 |
|
|
2022
Q4 | – | Sell |
-910
| Closed | -$263K | – | 257 |
|
|
2022
Q3 | $263K | Sell |
910
-131
| -13% | -$37.9K | 0.07% | 112 |
|
|
2022
Q2 | $293K | Buy |
1,041
+81
| +8% | +$22.8K | 0.08% | 113 |
|
|
2022
Q1 | $251K | Buy |
960
+286
| +42% | +$74.8K | 0.06% | 145 |
|
|
2021
Q4 | $148K | Buy |
+674
| New | +$148K | 0.04% | 211 |
|